Abraxis Bioscience has added a research facility to expand the
company's research and process development capabilities that use
the company's nab technology platform, which identifies new
chemical entities and exploitation...
SAFC Biosciences has unveiled an analogue of insulin specifically
designed for the large-scale manufacturing of recombitant
biopharmaceuticals, promising security of supply and product
consistency.
In its second acquisition in less than a month, Millipore has
acquired bioprocessing products firm Serologicals for around $1.4bn
(€1bn) in cash, as it tries to boost its growth by expanding in
potentially lucrative market segments.
Contract manufacturing services provider Dowpharma, has signed a
collaboration agreement for its Pfenex Expression Technology, its
fourth agreement in 1Q 2006, signifying the technology's popularity
in developing new vaccines...
Thanks to a £2.7m (€3.9m) access fund from the UK's National
Biomanufacturing Centre (NBC), biotech firm Onyvax has hired
contract manufacturer organisation (CMO) Eden Biodesign to supply
it with clinical current good manufacturing...
US filtration giant Millipore is pumping more resources into its
personnel and facilities in Asia, as outsourcing trends and new
laboratory investments in emerging markets such as China and India
are upping demand for its bioscience...
Rapid growth in the biopharmaceutical sector in China, India and
Southeast Asia has prompted US filtration specialist Pall to devote
more resources and industry experts to these regions, as the 14 per
cent growth seen in its BioPharm...
Filtration systems specialist Pall's net profit barely moved in Q2
compared to the similar period last year, up only $400,000
(€331,328) to $32.4m, still its Biopharmaceuticals business, driven
by a steady demand in consumables,...
Swiss custom manufacturing firm Lonza has entered into a joint
venture with investment management company Bio*One Capital to built
a $250m (€210m) large-scale mammalian cell culture plant in
Singapore, underlying Lonza's confidence...
Life sciences firm Cambrex has reported a $140.3m (€116.7m) loss in
Q4 as opposed to a profit of $4.9m in Q4 last year, hit by lower
long-term profitability projections for its Biopharma unit, as
biotech companies seem to lose their...
French firms PCAS and Proteus have decided to pool their expertise
to create a new biotech company which will provide APIs and
intermediates on a large scale, looking to offer new products and
also capitalise on the growing demand...
Dow AgroSciences has received the world's first regulatory approval
for a plant-made vaccine for animals, which not only represents a
new category of plant-made vaccines but also paves the way for
human vaccines made in a bio-contained...
Amgen are to create a European Development Centre significantly
boosting UK drug R&D. The announcement echoes the UK
Government's commitment to attract more R&D investment with a
view to making the UK a leader in biotechnology.
Filtration specialists, Pall, and Biotrace have signed an agreement
to market microbiological air monitoring technology to the
pharmaceutical industry. The deal focuses on microbiological
monitoring of manufacturing processes, which...
Bayer has acquired Icon Genetics in a culmination of an existing
agreement between the two companies. The deal also solidifies
Bayer's direction as it soughts to strengthen its efforts to
produce specific plant-made pharmaceuticals.
Centocor has enlisted Cardinal Health to use its rapid cell line
development technology to engineer cell lines expressing Centocor's
monoclonal antibodies, and speed up the development of new
biopharmaceuticals.
Dutch biotechnology company Crucell continues to push its PER.C6
cell line forward into the worldwide market, with a new agreement
now enabling the revolutionary vaccine technology to be used to
manufacture vaccines in Canada.
Crucell and DSM will further expand the development of its PER.C6
protein and monoclonal antibody licensing business by establishing
joint R&D centres on the US East Coast and in the Netherlands.
Wyeth are to establish a Bio-therapeutic Drug Discovery Research
Facility in Dublin in a move that adds to Wyeth Grange Castle
Campus in Ireland's capital and reinforces the growth of Ireland's
biotechnology research and...
In the same week that saw Novartis threaten its planned merger with
Berna Biotech, Dutch biotech company Crucell has signed three new
licensing agreements for its PER.C6 and STAR manufacturing
technologies.
Budding biotech company Artelis is the first to benefit from
Solvay's new strategy to undertake 50 per cent of its new projects
in partnership with outside start-up companies.
The European Commission has profiled the top 100 biotech technology
offers in a new brochure, which showcases the offers in such a way
that encourages European researchers to pursue the exploitation of
their own research results.
SR Pharma, specializing in RNAi therapeutics, will be the first
company to use the new UK National Biomanufacturing Centre (NBC),
operated by contract manufacturing organization (CMO) Eden
Biodesign, when it opens on schedule early...
As low-cost contract manufacturing organisations (CMO) in Asia are
becoming more attractive to drug companies, Western CMOs are having
to develop new business strategies in order to compete.
Cook Pharmica will be the first contract manufacturer to offer live
webcam services, an innovation that will enable both customers and
regulatory agencies to view production as it occurs.
The Advanced Biosciences division of US specialty materials maker
Rohm and Haas has decided to sell its entire range of solutions for
the production of biopharmaceuticals directly to customers.
According to a new report, the biopharmaceutical market is
predicted to increase from $1.4 billion (€1.14 billion) in 2003 to
$2.6 billion in 2006. The market was dwarfed by the pharmaceutical
industry 20 years ago but continues to...
India's leading biotechnology company, Bharat Biotech, has said it
intends to spend more than €10 million on the construction of a
manufacturing facility in Perak, Malaysia, to mass produce
hepatitis B, typhoid and malaria vaccines.
Profos AG, located in Regensburg, Germany, has raised €5 million in
a financing round aimed at supporting the development of an
endotoxin detection system with applications in biopharmaceutical
production.
Swiss chemicals firm and contract manufacturer Lonza fulfilled its
promise of stronger financial results in the first half of 2005,
with profits coming in at the lower end of the forecast range, but
still on target, reports Phil Taylor.
Lab and process equipment company Sartorius closed the first half
of 2005 with increases in sales revenue and earnings, with a good
performance by its filter business driven by demand from the
biopharmaceutical industry.
Manufacturing consolidation and acquisition costs helped reduce net
income as Millipore revealed its 2005 second quarter financial
results. The company has just completed the purchase of two
companies with the intention of increasing...
Cardinal Health has completed the manufacturing of an antibody
destined for human clinical trials, using a cell line that was made
with its patented GPEx (Gene Product Expression) technology.
Lonza has started a SF 14 million (€9m) expansion of its biologics
manufacturing facility in Slough, UK, in response to what it said
was increasing demand for mammalian cell production for clinical
trials, reports Phil Taylor.
A US company has revealed a unique method in drug development that
uses transgenic tobacco plants to cultivate the human protein
CaroRx, which could prevent tooth decay in the future.
Dublin City University in Ireland and pharmaceutical major Wyeth
have started a four-year research collaboration aimed at improving
the production of biopharmaceuticals, reports Phil Taylor.
Scientists have successfully achieved the production of a
functional humanised antibody in the whites of eggs laid by a
transgenic hen, opening the door to using transgenic flocks as an
alternative to mammalian cell culture for the...
Lonza has won a major new contract for its biopharmaceutical
manufacturing facility in Visp, Switzerland, making bulk actives
for Belgian company UCB, reports Phil Taylor.
Millipore has introduced a single-use prefilter for clarification
steps in mammalian cell synthesis that continues the trend towards
increasing use of disposable technologies in the bioprocessing
environment, reports Phil Taylor.
India now has its sights firmly set on the biotechnology industry,
having already emerged as a dynamic new player in the global market
for chemical-based pharmaceuticals, reports Phil Taylor.
Pall has launched a new gas filter that should increase safety in
the production of biologic drugs that need to be made in an
oxygen-enriched environment, writes Phil Taylor.
Genetically modified (GM) plants are to be used to grow vaccines
for use in the worldwide fight against HIV, tuberculosis, diabetes
and rabies thanks to a grant of €12 million from the European
Union, reports Phil Taylor.
A second market research report has found evidence that production
capacity in the market for contract manufacturing of
biopharmaceuticals is now in excess, in contrast to the hitherto
prevailing wisdom that the sector has been suffering...
Integra Biosciences has launched the CELLine disposable flask,
which harnesses membrane technology that is suitable for
recombinant protein expression and high yield monoclonal antibody
production.
Canada's Chromos Molecular Systems and AppTec Laboratory Services
have teamed up to provide the biopharmaceutical industry with a
broader range of cell line engineering and contract manufacturing
services.
